Literature DB >> 26343031

[Risk analysis study for patients care in radiotherapy: Learning curve and methodological evolution].

S El Bakri1, B Fleury2, M Le Grévellec2.   

Abstract

PURPOSE: To describe the evaluation of our risk mapping methodology over the past two years.
MATERIALS AND METHODS: Based on the FMEA (failure mode effects analysis) method, some aspects have been adapted, e.g. the concept of risk control and effort scale, some others have been introduced, e.g. the concept of residual risk management. A weekly meeting is scheduled by a multidisciplinary team in order to support the different projects.
RESULTS: Experiments and practice have led us to upgrade our scales of gravity and detectability, identify critical points and introduce the residual risk management concept. Some difficulties with regards to the multiplicity of scenarios still prevail.
CONCLUSION: Risk mapping is an essential tool in the implementation of risk quality management, specifically when the methodology is progressive and takes into consideration all the members of a pluridisciplinary team.
Copyright © 2015 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Cartographie des risques; Gestion du risque résiduel; Quality; Qualité; Residual risk management; Risk mapping

Mesh:

Year:  2015        PMID: 26343031     DOI: 10.1016/j.canrad.2015.05.023

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  1 in total

1.  Subcontracting sterile pediatric and adult chemotherapy preparations activity: A global risk analysis.

Authors:  Julia Rousseau; Kaouther Zribi; Camille Cotteret; Ambroise Marcais; Sarah Winter; Gabriel Salguero-Hernandez; Salvatore Cisternino; Joël Schlatter
Journal:  Health Sci Rep       Date:  2022-06-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.